Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 7(1): 4203, 2017 06 23.
Article in English | MEDLINE | ID: mdl-28646227

ABSTRACT

Despite zinc oxide nanoparticles (ZnONPs) being increasingly used as carriers in biomedical fields due to their multifaceted properties and therapeutic importance, better understanding of the mechanisms and cellular consequences resulting from their interaction with cells and cellular components has been warranted. In the present study, we investigate the size-dependent interaction of ZnONPs on RBCs, and its impact on cell viability, DNA damage, ROS generation and morphological changes, employing cellular and analytical methods. Size, charge, stability and solubility were confirmed by DLS, zeta potential, ICP-AES and TEM analysis. Further ICP-AES, TEM, spectroscopic observations and cell based assays showed that ZnONPs exhibited a size dependent impact on RBCs and haemoglobin (Hb), particularly size <50 nm. Conversely, ferulic acid (FA) conjugates and serum albumin significantly reduced the adverse effects exhibited by ZnONPs. The extent of DNA damage and ROS generation is comparatively low in ZnONPs-FA than in ZnONPs alone treated cells. Thus our study documents a novel conceptualization delineating the influence of size on the material properties and therapeutic potential of nanoparticle.


Subject(s)
Coumaric Acids/pharmacology , Erythrocytes/drug effects , Hemolysis/drug effects , Nanoparticles/toxicity , Particle Size , Zinc Oxide/toxicity , Albumins/metabolism , Cell Survival/drug effects , DNA Damage , Erythrocytes/cytology , Erythrocytes/ultrastructure , Hemoglobins/metabolism , Humans , Reactive Oxygen Species/metabolism , Solubility , Spectrometry, Fluorescence , Spectrum Analysis, Raman
2.
Biomed Pharmacother ; 88: 325-334, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28119234

ABSTRACT

One of the pivotal mechanisms projected for bioflavonoids in cancer chemoprevention is through their intervention against mutagen-DNA interaction. Recent literatures emphasize the role of troxerutin (TXER) as an emerging anticancer agent. However, there are no reports on its intervention in any carcinogen-DNA interaction. The present study investigates the possibility of TXER, in prevention of 2-aminoanthracene (2-AA) contact with DNA. Steady state and time resolved fluorescence spectroscopy results, highlight the direct contact of 2-AA with DNA, while presence of TXER prevented this interaction. Gel-electrophoresis study clearly revealed that, TXER inhibits 2-AA+UVA radiation induced DNA damage. Fluorescence microscopic studies elucidated that, TXER treatment obstructs the 2-AA interaction with cellular DNA, while molecular docking showed the energetically favourable structure of TXER/2-AA/TXER complex. Further anti-mutagenicity experiment revealed that, TXER prevents the mutation induced colony formation in mutant strain of S. typhymurium. Our in vitro and ex vivo experimental findings provide imperative evidence about the protective role of TXER against environmental carcinogens through the inhibition of carcinogen-DNA interaction, implicating its potential for therapeutic applications in cancer.


Subject(s)
Anthracenes/toxicity , Antimutagenic Agents/pharmacology , DNA/drug effects , Hydroxyethylrutoside/analogs & derivatives , Mutagens/toxicity , 3T3 Cells , Animals , DNA Damage/drug effects , Genotype , Hydroxyethylrutoside/pharmacology , Mice , Models, Molecular , Molecular Docking Simulation , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Sophora/chemistry , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL